🎗️Лента новостей
Онкология
Healio Community to host Mentorship Networking Event
On Sept. 23, Healio Community will host its first Mentorship Networking Event at 4 p.m. EDT, featuring an opportunity to connect with a mentor and gain career advice. The free webinar includes insights from four mentors in a range of specialties: Priya Bansal, MD, clinical assistant professor at Northwestern Feinberg…
Онкология
Sylvester Comprehensive Cancer Center Researchers Discover Why Some Lymphomas Resist CAR T-cell Treatment
Sylvester Comprehensive Cancer Center Researchers Discover Why Some Lymphomas Resist CAR T-cell Treatment University of Miami
🎗️
Онкология
Gynecologic Cancer Awareness: Dr. Teplinsky Discusses Nursing Roles
Gynecologic Cancer Awareness: Dr. Teplinsky Discusses Nursing Roles oncnursingnews.com
Онкология
Young, Healthy, and Facing Stage 4 Lung Cancer
Young, Healthy, and Facing Stage 4 Lung Cancer American Lung Association
Онкология
WCLC 2026: The lung cancer drug development readouts that caught our eye
WCLC 2026: The lung cancer drug development readouts that caught our eye Labiotech.eu
Онкология
Funding Approved For New UIC Cancer Research Center
Funding Approved For New UIC Cancer Research Center Chicago YIMBY
Онкология
Scientists discover cells that cheat death and rebuild damaged tissue
Scientists discovered a population of cells that can start the process of programmed cell death, survive it, and then help rapidly rebuild damaged tissue. Their descendants become far more resistant to future damage, revealing a mechanism that could improve healing but may also help cancers return after treatment.
🎗️
Онкология
Переболевшие раком рассказали о первых настораживающих симптомах
Переболевшие раком рассказали о первых настораживающих симптомах Главный Региональный
Онкология
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC) BioSpace
🎗️
Онкология
How Cancer Research Turned ‘Terminal’ Into ‘Curable’
How Cancer Research Turned ‘Terminal’ Into ‘Curable’ Eye On Sun Valley
Онкология
Раскрыт механизм, позволяющий половине всех видов рака скрываться от уничтожения
Раскрыт механизм, позволяющий половине всех видов рака скрываться от уничтожения hightech.plus
🎗️
Онкология
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer Business Wire
